Author: Christopher John Lisee

Posts by Christopher:

• How Should the FDA Evaluate Psychedelic Medicine? Posted on November 9, 2023 (March 17, 2024) by Christopher John Lisee in Research
• Race, ethnicity moderate the associations between lifetime psilocybin use, crime arrests Posted on August 23, 2023 (March 17, 2024) by Christopher John Lisee in Research
• Psychedelics, Related Pharmacotherapies as Integrative Medicine for Older Adults in Palliative Care Posted on May 12, 2023 (March 19, 2024) by Christopher John Lisee in Research
• Pressing regulatory challenges for psychedelic medicine Posted on April 27, 2023 (March 17, 2024) by Christopher John Lisee in Research
• Pharmacotherapy, Ketamine Assisted Psychotherapy for Treatment-Resistant Depression: A Patient With Lifelong Self-Doubt, Self-Criticism Posted on April 5, 2023 (March 17, 2024) by Christopher John Lisee in Research